1. Executive Summary
- Median SDE Multiple (GP)
- 3.8×
- SDE Multiple Range
- 3.2× – 4.5×
- EBITDA Multiple Range
- 4.0× – 6.5×
- Example: $450K SDE Practice
- ~$1.7M value
A typical US general dental practice in 2026 is worth 3.2×–4.5× SDE (Seller's Discretionary Earnings), with a median of 3.8×. For a practice generating $1.8M in collections and $450K SDE, that translates to an approximate value of $1.4M–$2.0M, with a midpoint near $1.7M. Valuation is driven by profitability, payer mix, hygiene production, facility lease terms, geographic market, and transition risk — not collections alone.
- SDE = Net income + owner doctor compensation + interest + depreciation + discretionary expenses. It is the standard metric for practices under $3M in collections.
- EBITDA multiples (4.0×–6.5×) apply to larger groups and DSO acquisitions where owner comp is normalized.
- Revenue multiples (0.6×–1.0×) are a secondary check — useful for rapid screening but unreliable without margin analysis.
- Associate buyouts typically price at 3.0×–3.8× SDE with seller financing over 5–10 years.
2. Market Sizing & Financial Overview
The US dental services market (~$178B, 2026) supports an active practice transaction market estimated at $4–$6B annually in practice sales (ADS Dental Transitions). With ~150,000 dental offices and ~3,000–4,000 annual transactions, the median deal size is $800K–$2.5M. IBISWorld projects 3.1% industry CAGR, supporting stable valuation multiples despite rising interest rates.
| Valuation Method | Multiple Range | Best Applied To |
|---|---|---|
| SDE Multiple | 3.2× – 4.5× | Solo & small GP practices (<$3M revenue) |
| EBITDA Multiple | 4.0× – 6.5× | Multi-location groups, DSO acquisitions |
| Revenue Multiple | 0.6× – 1.0× | Screening only; margin-dependent |
| Asset / Equipment | Fair market value | Distressed or startup practices |
- Annual US Practice Transactions
- 3,000 – 4,000
- Median Transaction Price (GP)
- $1.2M – $1.8M
- Average Days on Market
- 120 – 180
- DSO Acquisition Premium
- +0.3× – 0.8× SDE
Average EBITDA margins of 22–26% underpin current multiples. Practices below 18% EBITDA trade at 2.8×–3.2× SDE or below; top-quartile practices with >28% EBITDA, strong hygiene programs, and >50% FFS mix command 4.0×–4.5× SDE.
3. Competitive Landscape
The dental practice M&A market is bifurcated between individual buyers (associates, partners) and institutional buyers (DSOs, PE-backed platforms) — with materially different valuation approaches and competitive dynamics.
- DSO buyers represent ~40–50% of transactions by volume in 2025–2026, often paying 0.3×–0.8× SDE premium over individual buyers for well-located, profitable offices.
- Individual buyers (associate buy-ins, partner expansions) dominate transactions under $1.5M, typically at 3.0×–3.8× SDE with seller financing.
- Private equity consolidation: Top 10 DSOs operate 3,500+ locations; PE dry powder continues to support acquisition activity despite 7–9% SBA loan rates.
- Seller demographics: ~42% of US dentists are age 55+ (ADA HPI), creating a 10-year wave of retirement-driven supply — an estimated 20,000+ practices will transition by 2035.
- Competitive bidding in desirable metros (Austin, Denver, Nashville, Phoenix) pushes multiples 0.5×–1.0× above rural benchmarks.
| Buyer Type | Typical Multiple | Deal Structure |
|---|---|---|
| Associate buy-in | 3.0× – 3.8× SDE | Seller note + SBA 7(a) |
| Individual investor/dentist | 3.2× – 4.2× SDE | SBA 7(a) + cash down 10–15% |
| Regional DSO | 3.8× – 5.0× SDE | Cash + earnout on production retention |
| National PE-backed DSO | 4.5× – 6.5× EBITDA | Cash + rollover equity |
4. Key Growth Drivers & Trends
Valuation premiums in 2026 accrue to practices positioned at the intersection of demographic demand, elective revenue mix, and technology-enabled scalability.
- Aging population & implant capacity: Practices with established implant/perio programs trade at +0.3×–0.5× SDE premium due to recurring high-value procedure demand from the 65+ cohort.
- Cosmetic and elective mix: Offices with >15% cosmetic production command higher multiples — buyers view elective revenue as FFS-insulated and margin-accretive.
- AI and digital infrastructure: Practices with digital workflows (CBCT, intraoral scanners, CAD/CAM, cloud PMS) reduce buyer capex risk and support +0.2×–0.3× valuation uplift.
- Hygiene program strength: Hygiene production >30% of total collections with >80% recall rate signals stable recurring revenue — a key due-diligence metric for DSO buyers.
- Clear aligner & specialty adjacency: In-house ortho/aligner capability adds $200K–$500K in transferable production value.
5. Major Operational Challenges
Valuation discounts arise from operational and structural risks that buyers price aggressively — often reducing multiples by 0.5×–1.5× SDE.
- Owner dependency: Practices where the owner produces >60% of total doctor production trade at 2.5×–3.2× SDE — buyers discount for patient attrition risk post-transition.
- PPO concentration: Practices with >75% PPO/insurance mix face 0.3×–0.5× multiple discount due to reimbursement uncertainty and fee-schedule renegotiation risk.
- Lease and facility risk: Short remaining lease terms (<5 years), unfavorable renewal clauses, or >$35/sq ft rent compress value $100K–$300K.
- Staff retention risk: Key hygienist or office manager departure post-sale can reduce collections 10–20% in year one — buyers structure earnouts or holdbacks (10–15%) to mitigate.
- Rising cost of capital: SBA 7(a) rates at 7–9% (2026) reduce buyer purchasing power; every 1% rate increase lowers affordable purchase price ~8–10% for leveraged buyers.
Valuation action plan: Owners planning exit within 3–5 years should target ≥24% EBITDA, reduce owner production below 50% of total, diversify payer mix toward ≥40% FFS, and secure ≥10-year lease with renewal options. These steps typically add $200K–$500K to exit value on a $450K SDE practice.